December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Synthetic Phosphorylated Carboxyl Terminal Region of Rhodopsin Can Be Crosslinked to Arrestin
Author Affiliations & Notes
  • JH McDowell
    Ophthalmology University of Florida Gainesville FL
  • WC Smith
    Ophthalmology University of Florida Gainesville FL
  • A Arendt
    Ophthalmology University of Florida Gainesville FL
  • RL Miller
    Ophthalmology University of Florida Gainesville FL
  • A Dinculescu
    Ophthalmology University of Florida Gainesville FL
  • PA Hargrave
    Ophthalmology University of Florida Gainesville FL
  • Footnotes
    Commercial Relationships   J.H. McDowell, None; W.C. Smith, None; A. Arendt, None; R.L. Miller, None; A. Dinculescu, None; P.A. Hargrave, None. Grant Identification: NIH grants EY06225, EY06226, EY08571, and awards from RPB to the department, WCS, and PAH
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1392. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JH McDowell, WC Smith, A Arendt, RL Miller, A Dinculescu, PA Hargrave; The Synthetic Phosphorylated Carboxyl Terminal Region of Rhodopsin Can Be Crosslinked to Arrestin . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1392.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To crosslink the synthetic, fully phosphorylated region of bovine rhodopsin comprising residues 330-348 to arrestin in order to determine part of its binding site. Methods: Two analogs of the fully phosphorylated synthetic peptide comprising residues 330-348 of bovine rhodopsin were synthesized: the unacetylated peptide (7P-peptide) and peptide with the amino terminus acetylated (Ac7P-peptide). These analogs were modified at their free amino groups with the bifunctional reagent N-(a-maleimidoacetoxy) succinimide ester (AMAS) that places a sulfhydryl reactive group on the free amino group. The modified peptide was then combined with arrestin and various cysteine mutants of arrestin. SDS-PAGE was performed to determine if the peptide crosslinked to arrestin. Crosslinking was detected by an increase in molecular weight as well as by immunoblots using MAb A11-82P that recognizes phosphorylated rhodopsin. Results: 7P-peptide was crosslinked to arrestin, but only to arrestin mutants that contained the native Cys143. The absence of the other two native cysteine residues had little effect on the crosslinking. In preliminary experiments, mutants with a cysteine residue in an exposed loop of arrestin (i.e. S156C /C143A, S199C/C143A, S156C/S199C/C143A, and S178C/C143A) but lacking Cys143 showed some evidence of crosslinking, but were not as effective as native arrestin or a V177C mutant that contained Cys143. Ac7P-peptide crosslinked to native arrestin but less effectively than 7P-peptide. A four-fold molar excess of the modified 7P-peptide to arrestin, based on the absorbance of the N-(a-maleimido) group, yielded 50% modification of arrestin after a 2 hour incubation while a similar concentration of modified Ac7P-peptide yielded slightly less than 10% modification. Conclusion: Rhodopsin's 7P-peptide can be crosslinked to native arrestin at Cys143. Crosslinking is more effective through the amino terminus of 7P-peptide than through the Lys339 side chain. The data suggest that the cross-linking is somewhat biospecific since crosslinking to the native arrestin was more effective than to mutants lacking Cys143 but containing a cysteine residue in an exposed loop. This suggests that the area near Cys143 comprises part of the binding site for the phosphorylated region of rhodopsin.

Keywords: 517 photoreceptors • 515 phosphorylation • 527 protein structure/function 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×